Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.

"AP and MBM are investigators of a trial on IVIG for NSTI patients, partly funded by CSL Behring. The remaining authors have no conflicts of interest.: The authors report no conflicts of interest."

"This work was supported by European Union's Seventh Framework Programme (305340), Rigshospitalet Research Foundation (E-22514-02), and Aase and Ejnar Danielsen Foundation (10-001274). LSR has received funding from the TrygFonden (109662). PG and KP have received funding from the Danish Heart Association (16-R107-A6650-22966) and the Danish Council of Independent Research (DFF—6110-00489). US has received funding from the Danish Heart Association (14-R97-A5294-22846). OHY has received funding from the European Union's Seventh Framework Programme through the INFECT (305340; http://www.fp7infect.eu/)."

"In Denmark, the treatment of NSTI has been centralized at Rigshospitalet, University of Copenhagen, where this prospective, observational cohort study was conducted between February 2013 and April 2015. The study protocol has been published () and is available online (ClinicalTrials.gov: NCT02180906)."